The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study.
Johannes OldenburgJohnny N MahlanguWillem BujanPeter TraskMichael U CallaghanGuy Aaron YoungElina AsikaniusFlora PeyvandiElena SantagostinoRebecca Kruse-JarresClaude NegrierCraig KesslerJin XuJerzy WindygaMidori ShimaSylvia von MackensenPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2018)
In PwHA with inhibitors, emicizumab prophylaxis was associated with substantial and meaningful improvements in health-related outcomes.